Ingrid U. Scott, MD, MPH; Neal L. Oden, PhD; Paul C. VanVeldhuisen, PhD; et al.
JAMA Ophthalmol. 2022;140(5):458-464. doi:10.1001/jamaophthalmol.2022.0352
This post hoc analysis of the Study of Comparative Treatments for Retinal Vein Occlusion 2 trial compares baseline characteristics, treatment burden, and outcomes of macular edema treatment in participants with hemiretinal vein occlusion (HRVO) with those with central retinal vein occlusion (CRVO).
Kellyn N. Bellsmith, MD; Michael J. Gale, MD; Sen Yang, BS; et al.
free access
JAMA Ophthalmol. 2022;140(5):465-471. doi:10.1001/jamaophthalmol.2022.0396
This comparative effectiveness research study compares at-home visual acuity tests with in-office acuity measurements to validate their use with telehealth appointments.
-
Invited Commentary
Valid but Undervalued
Ji-Peng Olivia Li, MA, FRCOphth; Pearse A. Keane, FRCOphth, PhD; Peter Thomas, FRCOphth, PhD
Jinhua Bao, PhD; Yingying Huang, MD; Xue Li, PhD; et al.
open access
JAMA Ophthalmol. 2022;140(5):472-478. doi:10.1001/jamaophthalmol.2022.0401
This randomized clinical trial aimed to evaluate whether spectacle lenses with aspherical lenslets slow myopia progression over 2 years and whether the level of lenslet asphericity affects myopia control efficacy in a dose-dependent manner.
-
Invited Commentary
Clinical Relevance of Myopia Control With Specialized Spectacles
David C. Musch, PhD, MPH; Steven M. Archer, MD
Mahyar Etminan, PharmD, MSc; Mohit Sodhi, MSc; Frederick S. Mikelberg, MD; et al.
JAMA Ophthalmol. 2022;140(5):480-484. doi:10.1001/jamaophthalmol.2022.0663
This cohort study examines the risk for serous retinal detachment, retinal vascular occlusion, and ischemic optic neuropathy among men receiving phosphodiesterase type 5 inhibitors.
-
Invited Commentary
Phase 4 Studies on Phosphodiesterase 5 Inhibitors
Brian L. VanderBeek, MD, MPH, MSCE; Maureen G. Maguire, PhD
Felicia Widyaputri, MD, PhD; Sophie L. Rogers, MEpi; Rathika Kandasamy, MD; et al.
JAMA Ophthalmol. 2022;140(5):486-494. doi:10.1001/jamaophthalmol.2022.0050
This systematic review and meta-analysis investigates the prevalence of diabetic retinopathy and its progression in pregnant women with preexisting type 1 or type 2 diabetes.
-
Invited Commentary
Diabetic Retinopathy in Pregnancy
Janet S. Sunness, MD; Sidney A. Schechet, MD
Reem Karmouta, BS; Marie Altendahl, BA; Tahmineh Romero, MS; et al.
JAMA Ophthalmol. 2022;140(5):496-502. doi:10.1001/jamaophthalmol.2022.0667
This cohort study examines data for preterm neonates to investigate the association of socioeconomic factors in the context of race and ethnicity with retinopathy of prematurity outcomes.
Sara Giammaria, MD; Donna M. Hutchison, BSc; Paul E. Rafuse, MD, PhD; et al.
has audio
JAMA Ophthalmol. 2022;140(5):504-511. doi:10.1001/jamaophthalmol.2022.0671
This cohort study assesses the rates of visual field change in patients with glaucoma compared with healthy individuals during a median of 25 years of follow-up and identifies important covariates associated with those rates.
-
Audio Author Interview:
Rates of Visual Field Change in Individuals With and Without Glaucoma
Sean T. Berkowitz, MD, MBA; Jonathan Siktberg, BBA; Arulita Gupta, BS; et al.
JAMA Ophthalmol. 2022;140(5):512-518. doi:10.1001/jamaophthalmol.2022.0798
This economic evaluation assesses US Medicare & Medicaid Services’ Merit-Based Incentive Payment System scoring and reporting for ophthalmologists.